CD274 and breast carcinoma: Characterization of the immune components in the 4T1 breast cancer model revealed that cell-to-cell interactions between MDSCs (CD11b+Gr-1+) and B cells alter B cell functions (proliferation, apoptosis, and secretion of cytokines and antibodies) and expression of checkpoint-associated molecules PD-1 and PD-L1.